10.11.2022
Omówienie artykułu: Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
Lancet Oncol., 2022; 23: 382–392; DOI: https://doi.org/10.1016/S1470-2045(21)00758-0